US Stock MarketDetailed Quotes
OMGA Omega Therapeutics
- 0.977
- +0.094+10.68%
Close Dec 2 16:00 ET
- 0.960
- -0.018-1.82%
Post 20:01 ET
54.11MMarket Cap-740P/E (TTM)
1.020High0.890Low373.26KVolume0.890Open0.883Pre Close361.21KTurnover1.73%Turnover RatioLossP/E (Static)55.37MShares6.30052wk High4.70P/B21.05MFloat Cap0.75052wk Low--Dividend TTM21.54MShs Float31.410Historical High--Div YieldTTM14.72%Amplitude0.750Historical Low0.967Avg Price1Lot Size
About Omega Therapeutics Company
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
Company Profile
SymbolOMGA
Company NameOmega Therapeutics
Listing DateJul 30, 2021
Issue Price17.00
Founded2016
CEOMr. Mahesh Karande
MarketNASDAQ
Employees94
Fiscal Year Ends12-31
Address140 First Street,Suite 501
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-949-4360
Company Executives
- Name
- Position
- Salary
- Dr. Kaan Certel, PhD
- Director, President and Chief Executive Officer
- --
- Dr. Thomas McCauley, PhD
- Chief Scientific Officer
- --
- Ling Zeng, J.D.
- Chief Legal and Administrative Officer
- --
- Barbara Y. Chan
- Principal Financial Officer and Principal Accounting Officer
- --
- Christian Stanton Schade
- Chairman of the Board
- 135.55K
- Robert L. Rosiello
- Director
- --
- Rainer J. Boehm, M.B.A.
- Independent Director
- 148.68K
- Dr. Richard A. Young,PhD
- Independent Director
- 265.18K
- Michelle C. Werner
- Independent Director
- 97.51K
- Mary T. Szela
- Independent Director
- 153.68K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 149.19K
- Richard N. Kender, M.B.A.
- Independent Director
- --
- Dr. John D. Mendlein, J.D.,PhD
- Independent Director
- 151.29K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
